Back to News
Market Impact: 0.2
Boston Scientific Consensus Price Target Lowered by 10.06% to $57.12
Source: Nasdaq
Analyst EstimatesAnalyst Insights
Boston Scientific’s average one-year analyst price target was revised to $57.12 per share, down 10.06% from the prior $63.51 estimate dated October 20, 2026. The article provides no explanation for the revision or share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
BSX-0.20
More News
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game
- Apple reports after the bell. Options traders expect a big move
- Mizuho lowers Lumentum stock price target on Marvell acquisition
- Why is Apple stock falling afterhours today?
- RA Capital Management sells $9.13M in Lenz Therapeutics shares